As number of risk factors increased, increase was seen in number of plaques and plaques with vulnerable phenotype
TUESDAY, July 28, 2026 (HealthDay News) — Cardiovascular risk factors (RFs) are associated with increased plaque burden, according to a study published online July 23 in JACC Advances.
Jakub Chmiel, M.D., from Harvard Medical School in Boston, and colleagues examined the association between RFs and pan-coronary plaque burden, plaque phenotype, and features of vulnerability. Modifiable and nonmodifiable RFs were recorded in patients undergoing three-vessel optical coherence tomography imaging.
The analysis included 534 plaques from 131 patients. The researchers found that the number of plaques and plaques with a vulnerable phenotype (thin-cap fibroatheromas [TCFAs]) increased as the number of RFs increased. In addition, a higher number of vulnerable features was seen in association with an increasing number of RFs, including more thin fibrous caps, lipid-rich plaques (LRPs), macrophages, microvessels, and cholesterol crystals. Only modifiable RF burden was associated with increased pan-coronary vulnerability in a multivariable analysis (incidence rate ratio, 1.36), including a higher prevalence of TCFAs, LRPs, and cholesterol crystals (incidence rate ratios, 1.48, 1.35, and 1.50, respectively).
“The higher the number of vulnerable, or rupture-prone plaques, the greater the chance that one of them will trigger an adverse event,” senior author Ik-Kyung Jang, M.D., Ph.D., from Mass General Brigham Heart and Vascular Institute in Boston, said in a statement. “Our findings highlight the importance of early, intensive, and sustained interventions to control the modifiable risk factors and prevent future events.”
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus
Eating More Whole Grains Daily Linked to Cardiometabolic Benefits
Report Highlights Substance Use in Young Adults in U.S. in 2025
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes